# 美國最高法院拒絕審理藥品產業對醫療保險藥品價格談判計畫的挑戰。

*biotech · news · 2026-05-19 · Benzinga*

## Key points

- 最高法院拒絕審理藥品產業對醫療保險藥品價格談判的挑戰。
- 今年已有10種藥品在醫療保險下的首批談判價格生效。
- CMS估計第二輪談判價格在2024年可為醫療保險節省約85億美元。
- 白宮經濟學家預測，該更廣泛藥品定價框架在10年內可節省5290億美元。

The U.S. Supreme Court on Monday declined to hear a pharmaceutical industry challenge to the Medicare drug price negotiation program created under former President Joe Biden's Inflation Reduction Act, according to Reuters. The companies argued the program imposed government-dictated price controls and threatened innovation. Reuters reported that the drugmakers also claimed the policy violated constitutional protections for due process, free speech and property rights. The Medicare negotiation framework allows the Centers for Medicare & Medicaid Services, or CMS, to negotiate prices directly with manufacturers for certain high-cost medicines covered under Medicare. Companies that refuse to participate could face steep excise taxes or withdraw products from Medicare programs. Program Expands The first negotiated prices for 10 drugs already took effect this year. The Trump administration has continued defending the Biden-era pricing mechanism as part of its broader effort to reduce prescription drug costs. CMS previously estimated that negotiated prices from the second cycle could have reduced Medicare spending by roughly $8.5 billion in 2024. "Under President Trump's leadership, CMS is taking strong action to target the most expensive drugs in Medicare," CMS Administrator Mehmet Oz said in January while announcing the latest negotiation cycle, according to Reuters. Pricing Debate White House economists previously estimated that the administration's broader drug-pricing framework could generate roughly $529 billion in savings over the next decade, while Medicaid savings could total approximately $64.3 billion. Sen. Peter Welch (D-Vt.) recently voiced support for the administration's "most favored nation" drug pricing model, calling for Congress to formally advance the proposal. Reuters noted that Americans pay more for prescription drugs than people in any other country. Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. Image via Shutterstock

**Countries:** United States

[Read the full story on Benzinga](https://www.benzinga.com/news/health-care/26/05/52654916/supreme-court-hands-major-blow-to-big-pharmas-fight-against-biden-era-medicare-drug-pricing-law)

---

Canonical: https://newsio.io/zh-TW/n/7382b296-519e-4b35-98cc-43624f8b7254/10
Summarized by Newsio from Benzinga. https://newsio.io/how-it-works